The effect of miR-223-3p on endothelial cells in coronary artery disease

In Vitro Cell Dev Biol Anim. 2024 Mar;60(2):151-160. doi: 10.1007/s11626-023-00842-7. Epub 2023 Dec 28.

Abstract

Endothelial cell damage and dysfunction are crucial factors in the development and early stages of coronary artery disease (CAD) and apoptosis plays a significant role in this process. In this study, We aimed to simulate the CAD vascular microenvironment by treating endothelial cells with tumor necrosis factor alpha (TNF-α) to construct an endothelial cell apoptosis model. Our findings revealed that the TNF-α model resulted in increased micro-RNA 223-3p (miR-223-3p) mRNA and Bax protein expression, decreased kruppel-like factor 15 (KLF15) and Bcl-2 protein expression, and decreased cell viability. More importantly, in the TNF-α-induced endothelial cell apoptosis model, transfection with the miR-223-3p inhibitor reversed the effects of TNF-α on Bcl-2, Bax expression. We transfected miRNA-223-3p mimics or inhibitors into endothelial cells and assessed miR-223-3p levels using RT-PCR. Cell viability was detected using CCK8. Western blot technology was used to detect the expression of Bcl-2, Bax, and KLF15. In summary, this study demonstrates the role and possible mechanism of miR-223-3p in endothelial cells during CAD, suggesting that miR-223-3p may serve as a promising therapeutic target in CAD by regulating KLF15.

Keywords: Apoptosis; Endothelial cells; KLF15; microRNA-223-3p.

MeSH terms

  • Animals
  • Apoptosis / genetics
  • Coronary Artery Disease* / genetics
  • Coronary Artery Disease* / pathology
  • Endothelial Cells / metabolism
  • MicroRNAs* / metabolism
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Tumor Necrosis Factor-alpha / metabolism
  • bcl-2-Associated X Protein / genetics

Substances

  • MicroRNAs
  • bcl-2-Associated X Protein
  • Tumor Necrosis Factor-alpha
  • Proto-Oncogene Proteins c-bcl-2